VeriMomVeriMom
HIGH RISK

임신 중 cannabidiol - synthetically produced을 피해야 할까요? | VeriMom

Evidence from animal and human-relevant studies shows cannabidiol (CAS 13956-29-1) transfers to the fetus and accumulates in fetal tissues in rodent models, and authorities have raised reproductive concerns (ANSES proposal and multiple C&L notifications listing H361), so reproductive hazard is 'suspected' rather than confirmed. SCCS evaluated CBD for cosmetic use and provided a dermal safe limit (0.19%), indicating risk is dose/exposure dependent; dermal absorption is measurable at cosmetic use levels. Sources: SCCS opinion, rodent PK study, ANSES position, ECHA C&L notifications.

ECHA regulatory hazard statements

  • H361

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

cannabidiol - synthetically produced은 임신 중 안전한가요?
Evidence from animal and human-relevant studies shows cannabidiol (CAS 13956-29-1) transfers to the fetus and accumulates in fetal tissues in rodent models, and authorities have raised reproductive concerns (ANSES proposal and multiple C&L notifications listing H361), so reproductive hazard is 'suspected' rather than confirmed. SCCS evaluated CBD for cosmetic use and provided a dermal safe limit (0.19%), indicating risk is dose/exposure dependent; dermal absorption is measurable at cosmetic use levels. Sources: SCCS opinion, rodent PK study, ANSES position, ECHA C&L notifications.
cannabidiol - synthetically produced은 모유 수유 중 안전한가요?
Regulatory and public-health authorities advise against CBD use while breastfeeding because cannabinoids can be transferred to infants (authoritative guidance from FDA and reviews), and animal data show developmental effects; mechanism evidence includes demonstrated maternal–infant transfer and pharmacologic activity in offspring. Measured systemic exposure after dermal use is generally low but nonzero, so breastmilk exposure from topical products is plausible at higher maternal systemic levels.
cannabidiol - synthetically produced은 아기 피부에 안전한가요?
Do not increase hazard/mechanism without infant-specific data, but increase exposure score for infant skin because infant epidermal barrier immaturity and higher surface-area-to-weight make absorption relatively greater. Given demonstrated maternal–fetal transfer and animal developmental effects, CBD remains a suspected reproductive/developmental hazard for infants if systemic exposure occurs.
VeriMom은 cannabidiol - synthetically produced을 어떻게 평가하나요?
VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 cannabidiol - synthetically produced을 20/100 (높은 위험)로 평가합니다.
임신 중 cannabidiol - synthetically produced 대체 안전 성분은?
유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.

모든 성분표를 2초 만에 확인

VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.

의료 면책 조항

이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.

VeriMom 앱에서 모든 기능을 이용해 보세요